Skip to content

BAK/Cervical Interbody Fusion System

by Sulzer Spine-Tech

PMA P980048

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P980048↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberP980048 Date20 Apr 2001DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Bak/Cervical (Bak/C) (R) Interbody Fusion System
Trade Name
Bak/Cervical (Bak/C) Interbody Fusion System
Generic Name
Intervertebral fusion device with bone graft, lumbar
PMA Number
FDA Product Code
MAX
Device Class
Class II
Regulation
21 CFR Part 888.3080
Advisory Committee
Orthopedic
FDA Decision
APRL

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BAK/Cervical Interbody Fusion System is an intervertebral fusion device designed for skeletal mature patients with degenerative disc disease (DDD) in the cervical spine, accompanied by radicular symptoms at a single disc level. It is intended to facilitate spinal fusion by providing structural support and stability at the C-3 to C-7 disc levels, using an anterior surgical approach in conjunction with autograft bone.

This system is supplied sterile and intended for single-use, with FDA_PMA authorization under PMA number P980048. Implants are placed via an anterior approach, and the device is regulated under the orthopedic product code MAX. Storage and handling must comply with sterile surgical instrument protocols, as specified in the accompanying instructions for use.

Other devices from Sulzer Spine-Tech

See all devices from Sulzer Spine-Tech →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What cervical spine levels is the BAK/Cervical Interbody Fusion System approved for use in patients with degenerative disc disease and radicular symptoms?

    The BAK/Cervical Interbody Fusion System is approved for use at the C-3 to C-7 disc levels in skeletally mature patients with degenerative disc disease (DDD) and accompanying radicular symptoms at a single disc level. This is based on the device’s intended use as described in the advisory committee statement and PMA authorization.

  • How is the BAK/Cervical Interbody Fusion System supplied, and is it reusable?

    The BAK/Cervical Interbody Fusion System is supplied sterile and is intended for single-use only. Since it is designed for surgical implantation and sterilized for one-time use, reuse is not recommended or supported by the manufacturer or regulatory approval.

  • What surgical approach is required to implant the BAK/Cervical Interbody Fusion System, and what additional materials are needed?

    The BAK/Cervical Interbody Fusion System is placed via an anterior surgical approach at the specified cervical disc levels. The device is intended to be used in conjunction with autograft bone to facilitate spinal fusion, as outlined in the device description and advisory committee statement.

  • How should the BAK/Cervical Interbody Fusion System be stored, and what precautions should be taken?

    The BAK/Cervical Interbody Fusion System must be stored and handled according to sterile surgical instrument protocols to maintain its sterility. Since it is supplied sterile, proper packaging integrity and adherence to manufacturer instructions are critical to prevent contamination before use.